Gene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock Pops – Investor’s Business Daily

  1. Gene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock Pops  Investor's Business Daily
  2. 'Near cure' for rare disease costs $2.1 million but makers say it's better than ongoing treatment  ABC News
  3. Spinal muscular atrophy drug worth $3 million world’s most expensive  The New Daily
  4. $3 million: Gene therapy drug Zolgensma the world’s most expensive treatment  PerthNow
  5. US approves world’s costliest drug to treat rare childhood disorder  Hindustan Times
  6. View full coverage on Google News

Recent Entries

Leave a Reply

You must be logged in to post a comment.

css.php

© 2010-2019 Andrew and Karla's Place All original content copyright Andrew and Karla's Place. All rights reserved. No reproduction allowed without written permission.